Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Research Design | 23 | 2023 | 6180 | 2.920 |
Why?
|
Sleep Apnea, Obstructive | 26 | 2024 | 1875 | 2.050 |
Why?
|
Sample Size | 15 | 2023 | 841 | 1.840 |
Why?
|
Randomized Controlled Trials as Topic | 26 | 2023 | 10209 | 1.650 |
Why?
|
Models, Statistical | 11 | 2023 | 5079 | 1.430 |
Why?
|
HIV Infections | 38 | 2023 | 17351 | 1.390 |
Why?
|
Tonsillectomy | 7 | 2024 | 278 | 1.270 |
Why?
|
Adenoidectomy | 8 | 2024 | 167 | 1.260 |
Why?
|
Snoring | 7 | 2024 | 209 | 1.180 |
Why?
|
Sleep Apnea Syndromes | 12 | 2024 | 975 | 1.030 |
Why?
|
Cluster Analysis | 12 | 2023 | 2707 | 1.000 |
Why?
|
Actigraphy | 11 | 2023 | 520 | 0.980 |
Why?
|
HIV-1 | 23 | 2021 | 6863 | 0.960 |
Why?
|
Computer Simulation | 20 | 2023 | 6240 | 0.910 |
Why?
|
Digestive System Surgical Procedures | 3 | 2023 | 572 | 0.830 |
Why?
|
Data Interpretation, Statistical | 7 | 2020 | 2691 | 0.740 |
Why?
|
Polysomnography | 17 | 2023 | 1848 | 0.690 |
Why?
|
Cross Infection | 9 | 2021 | 1422 | 0.650 |
Why?
|
Population Groups | 1 | 2019 | 208 | 0.610 |
Why?
|
Sleep | 14 | 2018 | 4768 | 0.600 |
Why?
|
Algorithms | 8 | 2022 | 14031 | 0.590 |
Why?
|
Single-Parent Family | 1 | 2017 | 4 | 0.570 |
Why?
|
Anti-HIV Agents | 9 | 2020 | 4527 | 0.560 |
Why?
|
Viral Load | 16 | 2020 | 3332 | 0.550 |
Why?
|
Continuous Positive Airway Pressure | 7 | 2022 | 575 | 0.530 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1380 | 0.490 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2022 | 2199 | 0.490 |
Why?
|
Gastric Bypass | 1 | 2023 | 818 | 0.480 |
Why?
|
Likelihood Functions | 3 | 2023 | 992 | 0.480 |
Why?
|
Nevirapine | 2 | 2013 | 273 | 0.480 |
Why?
|
Epidemics | 5 | 2021 | 512 | 0.450 |
Why?
|
Catheter-Related Infections | 4 | 2020 | 273 | 0.440 |
Why?
|
Biostatistics | 2 | 2017 | 164 | 0.430 |
Why?
|
Sepsis | 7 | 2021 | 2585 | 0.430 |
Why?
|
Residence Characteristics | 3 | 2019 | 2093 | 0.430 |
Why?
|
HIV | 4 | 2019 | 1582 | 0.410 |
Why?
|
Random Allocation | 3 | 2021 | 2395 | 0.400 |
Why?
|
Cross-Sectional Studies | 20 | 2024 | 26125 | 0.400 |
Why?
|
Humans | 134 | 2024 | 761504 | 0.380 |
Why?
|
Zidovudine | 1 | 2013 | 624 | 0.370 |
Why?
|
Fluoxetine | 1 | 2015 | 733 | 0.370 |
Why?
|
Multicenter Studies as Topic | 3 | 2023 | 1702 | 0.370 |
Why?
|
CD4 Lymphocyte Count | 8 | 2020 | 2571 | 0.360 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 4 | 2013 | 206 | 0.350 |
Why?
|
Botswana | 11 | 2020 | 1048 | 0.340 |
Why?
|
Social Class | 3 | 2017 | 2004 | 0.330 |
Why?
|
Nonlinear Dynamics | 2 | 2023 | 492 | 0.330 |
Why?
|
Circumcision, Male | 2 | 2020 | 148 | 0.310 |
Why?
|
Preventive Health Services | 1 | 2013 | 567 | 0.300 |
Why?
|
Vaccines | 3 | 2022 | 844 | 0.300 |
Why?
|
Hypertension | 4 | 2022 | 8540 | 0.300 |
Why?
|
RNA, Viral | 8 | 2020 | 2846 | 0.300 |
Why?
|
Biometry | 1 | 2011 | 563 | 0.300 |
Why?
|
Hospitals | 10 | 2023 | 3882 | 0.300 |
Why?
|
Linear Models | 6 | 2023 | 5871 | 0.300 |
Why?
|
Surgical Wound Infection | 4 | 2023 | 1527 | 0.300 |
Why?
|
Medicare | 2 | 2023 | 6770 | 0.290 |
Why?
|
Dietary Supplements | 1 | 2020 | 3415 | 0.290 |
Why?
|
Drug Resistance, Viral | 1 | 2012 | 862 | 0.290 |
Why?
|
Probability | 3 | 2023 | 2477 | 0.290 |
Why?
|
Proportional Hazards Models | 7 | 2023 | 12463 | 0.280 |
Why?
|
Observer Variation | 1 | 2013 | 2606 | 0.280 |
Why?
|
Vitamin D | 1 | 2020 | 3303 | 0.270 |
Why?
|
Health Status Disparities | 1 | 2017 | 1852 | 0.240 |
Why?
|
Poverty | 1 | 2017 | 2698 | 0.240 |
Why?
|
Anti-Retroviral Agents | 5 | 2019 | 1784 | 0.240 |
Why?
|
Diagnostic Tests, Routine | 1 | 2010 | 787 | 0.240 |
Why?
|
Disease Outbreaks | 5 | 2021 | 1749 | 0.230 |
Why?
|
Urinary Catheterization | 3 | 2020 | 193 | 0.230 |
Why?
|
Incidence | 12 | 2020 | 21353 | 0.220 |
Why?
|
Atherosclerosis | 5 | 2018 | 3408 | 0.210 |
Why?
|
HIV Antibodies | 5 | 2018 | 1303 | 0.210 |
Why?
|
Marburg Virus Disease | 1 | 2022 | 11 | 0.210 |
Why?
|
Marburgvirus | 1 | 2022 | 19 | 0.210 |
Why?
|
Urinary Tract Infections | 2 | 2019 | 802 | 0.210 |
Why?
|
Clinical Trials as Topic | 5 | 2022 | 8002 | 0.200 |
Why?
|
Mass Screening | 5 | 2020 | 5428 | 0.200 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2022 | 12148 | 0.200 |
Why?
|
Infection Control | 4 | 2023 | 981 | 0.200 |
Why?
|
Watchful Waiting | 2 | 2023 | 491 | 0.190 |
Why?
|
Confidence Intervals | 2 | 2021 | 2927 | 0.190 |
Why?
|
Statistics as Topic | 1 | 2007 | 2358 | 0.190 |
Why?
|
Blood Pressure | 6 | 2022 | 8481 | 0.190 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2013 | 2151 | 0.180 |
Why?
|
Electrochemical Techniques | 1 | 2021 | 94 | 0.180 |
Why?
|
Female | 72 | 2024 | 392644 | 0.180 |
Why?
|
Male | 70 | 2024 | 360804 | 0.180 |
Why?
|
Communicable Diseases, Emerging | 1 | 2022 | 148 | 0.180 |
Why?
|
Quality Indicators, Health Care | 3 | 2019 | 1792 | 0.180 |
Why?
|
Immunoenzyme Techniques | 3 | 2013 | 1705 | 0.170 |
Why?
|
HIV Seropositivity | 5 | 2013 | 960 | 0.170 |
Why?
|
Reimbursement, Incentive | 3 | 2019 | 543 | 0.170 |
Why?
|
Middle Aged | 47 | 2021 | 220895 | 0.170 |
Why?
|
Community-Acquired Infections | 2 | 2020 | 469 | 0.160 |
Why?
|
HIV Envelope Protein gp120 | 2 | 2014 | 914 | 0.160 |
Why?
|
Sleep Stages | 3 | 2017 | 694 | 0.160 |
Why?
|
Longitudinal Studies | 8 | 2021 | 14605 | 0.160 |
Why?
|
Gastrectomy | 1 | 2023 | 672 | 0.150 |
Why?
|
Mediastinitis | 1 | 2018 | 49 | 0.150 |
Why?
|
United States | 24 | 2023 | 72334 | 0.150 |
Why?
|
Vaccination | 2 | 2022 | 3384 | 0.150 |
Why?
|
Asymptomatic Infections | 1 | 2019 | 131 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 250 | 0.150 |
Why?
|
Self Report | 4 | 2017 | 3724 | 0.140 |
Why?
|
Executive Function | 2 | 2023 | 1389 | 0.140 |
Why?
|
Survival Analysis | 1 | 2010 | 10090 | 0.140 |
Why?
|
Depressive Disorder, Major | 1 | 2015 | 4761 | 0.140 |
Why?
|
CA-19-9 Antigen | 1 | 2017 | 106 | 0.140 |
Why?
|
Drug Resistance, Microbial | 1 | 2020 | 825 | 0.140 |
Why?
|
Catheters, Indwelling | 1 | 2019 | 426 | 0.140 |
Why?
|
Minority Groups | 2 | 2023 | 1203 | 0.140 |
Why?
|
Information Management | 1 | 2017 | 100 | 0.140 |
Why?
|
Aged | 32 | 2023 | 169289 | 0.140 |
Why?
|
Rest | 2 | 2018 | 918 | 0.140 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2078 | 0.130 |
Why?
|
Multiple Organ Failure | 1 | 2019 | 387 | 0.130 |
Why?
|
Patient Compliance | 3 | 2019 | 2690 | 0.130 |
Why?
|
Sleep Apnea, Central | 1 | 2017 | 88 | 0.130 |
Why?
|
Weather | 1 | 2017 | 231 | 0.130 |
Why?
|
Adult | 36 | 2021 | 221177 | 0.130 |
Why?
|
Severity of Illness Index | 6 | 2020 | 15842 | 0.130 |
Why?
|
Positive-Pressure Respiration | 1 | 2020 | 639 | 0.130 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 311 | 0.130 |
Why?
|
Prevalence | 10 | 2020 | 15732 | 0.130 |
Why?
|
Child, Preschool | 9 | 2024 | 42230 | 0.120 |
Why?
|
Quality of Life | 6 | 2024 | 13367 | 0.120 |
Why?
|
Child | 15 | 2024 | 80153 | 0.120 |
Why?
|
Hospital Mortality | 5 | 2021 | 5294 | 0.120 |
Why?
|
Placebos | 1 | 2019 | 1667 | 0.120 |
Why?
|
Community Health Services | 2 | 2017 | 656 | 0.120 |
Why?
|
Demography | 2 | 2017 | 1648 | 0.120 |
Why?
|
Leukocyte Count | 1 | 2018 | 1596 | 0.120 |
Why?
|
Electronic Health Records | 4 | 2019 | 4811 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1440 | 0.110 |
Why?
|
Comorbidity | 5 | 2020 | 10508 | 0.110 |
Why?
|
Wrist | 1 | 2015 | 227 | 0.110 |
Why?
|
Young Adult | 16 | 2021 | 59243 | 0.110 |
Why?
|
Sleep Deprivation | 2 | 2023 | 846 | 0.110 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2017 | 411 | 0.110 |
Why?
|
Monitoring, Ambulatory | 1 | 2017 | 354 | 0.110 |
Why?
|
Anti-Bacterial Agents | 4 | 2021 | 7407 | 0.110 |
Why?
|
Adolescent | 15 | 2023 | 88319 | 0.110 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 15500 | 0.110 |
Why?
|
Risk Factors | 14 | 2021 | 74206 | 0.110 |
Why?
|
Carotid Artery Diseases | 1 | 2019 | 877 | 0.110 |
Why?
|
Time Factors | 14 | 2017 | 39967 | 0.110 |
Why?
|
Risk | 3 | 2020 | 9610 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2021 | 875 | 0.110 |
Why?
|
Microscopy, Fluorescence | 1 | 2020 | 2645 | 0.100 |
Why?
|
Virus Diseases | 1 | 2019 | 718 | 0.100 |
Why?
|
Publishing | 1 | 2020 | 833 | 0.100 |
Why?
|
Light | 1 | 2018 | 1353 | 0.100 |
Why?
|
Attention | 1 | 2023 | 2396 | 0.100 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2015 | 489 | 0.100 |
Why?
|
Eating | 1 | 2018 | 1539 | 0.100 |
Why?
|
Circadian Rhythm | 3 | 2018 | 2576 | 0.100 |
Why?
|
Socioeconomic Factors | 3 | 2020 | 7827 | 0.100 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2020 | 1897 | 0.100 |
Why?
|
Seasons | 1 | 2017 | 1520 | 0.100 |
Why?
|
Exercise | 2 | 2018 | 5890 | 0.090 |
Why?
|
Carbon Dioxide | 1 | 2015 | 1147 | 0.090 |
Why?
|
Blood Glucose | 2 | 2016 | 6391 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2011 | 4369 | 0.090 |
Why?
|
HLA-DR Antigens | 1 | 2012 | 602 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2018 | 868 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2024 | 0.090 |
Why?
|
RNA | 1 | 2020 | 2726 | 0.090 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2017 | 1081 | 0.090 |
Why?
|
Virus Replication | 2 | 2009 | 2435 | 0.090 |
Why?
|
Quality Improvement | 3 | 2019 | 3801 | 0.080 |
Why?
|
Child Behavior | 1 | 2015 | 847 | 0.080 |
Why?
|
Weight Gain | 1 | 2020 | 2348 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14666 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2015 | 6228 | 0.080 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 1048 | 0.080 |
Why?
|
False Negative Reactions | 1 | 2010 | 573 | 0.080 |
Why?
|
Intensive Care Units | 2 | 2019 | 3745 | 0.080 |
Why?
|
Fatty Acids | 1 | 2017 | 1808 | 0.080 |
Why?
|
Drug Administration Schedule | 3 | 2013 | 4853 | 0.080 |
Why?
|
Indoles | 1 | 2017 | 1833 | 0.080 |
Why?
|
Cohort Studies | 11 | 2022 | 41487 | 0.080 |
Why?
|
Double-Blind Method | 3 | 2020 | 12341 | 0.080 |
Why?
|
Neutrophils | 2 | 2018 | 3767 | 0.080 |
Why?
|
AIDS Serodiagnosis | 1 | 2009 | 220 | 0.080 |
Why?
|
Viral Vaccines | 2 | 2020 | 596 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2023 | 64680 | 0.080 |
Why?
|
Insulin | 2 | 2020 | 6596 | 0.070 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 819 | 0.070 |
Why?
|
Logistic Models | 5 | 2021 | 13255 | 0.070 |
Why?
|
Aged, 80 and over | 12 | 2021 | 58976 | 0.070 |
Why?
|
Immunophenotyping | 1 | 2012 | 1870 | 0.070 |
Why?
|
Critical Illness | 1 | 2020 | 2723 | 0.070 |
Why?
|
Prospective Studies | 13 | 2020 | 54425 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2023 | 80636 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3201 | 0.070 |
Why?
|
Coronary Artery Disease | 2 | 2017 | 6403 | 0.070 |
Why?
|
Motor Activity | 1 | 2017 | 2715 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1738 | 0.070 |
Why?
|
Drug Resistance, Multiple, Viral | 1 | 2006 | 53 | 0.070 |
Why?
|
Colorectal Neoplasms | 2 | 2021 | 6935 | 0.070 |
Why?
|
Evolution, Molecular | 2 | 2013 | 1886 | 0.070 |
Why?
|
Disease Progression | 2 | 2016 | 13506 | 0.070 |
Why?
|
Single-Blind Method | 2 | 2024 | 1572 | 0.070 |
Why?
|
Databases, Factual | 2 | 2018 | 7967 | 0.070 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3204 | 0.070 |
Why?
|
Critical Care | 1 | 2019 | 2696 | 0.070 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2013 | 1351 | 0.060 |
Why?
|
Lipids | 1 | 2017 | 3341 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6484 | 0.060 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1533 | 0.060 |
Why?
|
Life Style | 1 | 2017 | 3917 | 0.060 |
Why?
|
Asthma | 1 | 2024 | 6234 | 0.060 |
Why?
|
Quality Control | 1 | 2007 | 832 | 0.060 |
Why?
|
Phylogeny | 4 | 2016 | 2811 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3358 | 0.060 |
Why?
|
Obesity | 5 | 2024 | 12947 | 0.060 |
Why?
|
CD4-CD8 Ratio | 1 | 2003 | 114 | 0.060 |
Why?
|
ras Proteins | 1 | 2009 | 1054 | 0.060 |
Why?
|
Patient Isolators | 1 | 2023 | 11 | 0.060 |
Why?
|
Health Status | 1 | 2017 | 4077 | 0.060 |
Why?
|
Heart Rate | 1 | 2015 | 4195 | 0.060 |
Why?
|
Heart Ventricles | 1 | 2016 | 3807 | 0.060 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2006 | 621 | 0.050 |
Why?
|
Public Health | 1 | 2016 | 2669 | 0.050 |
Why?
|
Hospitalization | 2 | 2020 | 10723 | 0.050 |
Why?
|
Rural Population | 3 | 2019 | 2285 | 0.050 |
Why?
|
Aspergillus | 1 | 2023 | 93 | 0.050 |
Why?
|
Hydroxyurea | 1 | 2004 | 284 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 2016 | 3879 | 0.050 |
Why?
|
Propensity Score | 2 | 2021 | 1913 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8529 | 0.050 |
Why?
|
Mastectomy | 1 | 2011 | 1822 | 0.050 |
Why?
|
Patient Selection | 1 | 2014 | 4244 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2012 | 4580 | 0.050 |
Why?
|
Gene Deletion | 1 | 2010 | 2665 | 0.050 |
Why?
|
England | 1 | 2023 | 526 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2012 | 3702 | 0.050 |
Why?
|
Antibodies, Immobilized | 1 | 2021 | 23 | 0.050 |
Why?
|
Cognition | 2 | 2017 | 6990 | 0.050 |
Why?
|
Privacy | 1 | 2023 | 233 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2010 | 2571 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20098 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 3769 | 0.040 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2022 | 244 | 0.040 |
Why?
|
Selection Bias | 1 | 2022 | 359 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 891 | 0.040 |
Why?
|
AIDS Vaccines | 1 | 2006 | 896 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2865 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4243 | 0.040 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2009 | 2057 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2017 | 5368 | 0.040 |
Why?
|
Basic Reproduction Number | 1 | 2019 | 36 | 0.040 |
Why?
|
Contact Tracing | 1 | 2021 | 271 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2004 | 974 | 0.040 |
Why?
|
Diet | 1 | 2017 | 8075 | 0.040 |
Why?
|
Mutation | 4 | 2013 | 30052 | 0.040 |
Why?
|
Data Collection | 2 | 2018 | 3322 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2017 | 5127 | 0.040 |
Why?
|
Pharmacoepidemiology | 1 | 2022 | 350 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2023 | 1258 | 0.040 |
Why?
|
HIV Antigens | 1 | 2018 | 325 | 0.040 |
Why?
|
Cytokines | 1 | 2012 | 7396 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2019 | 397 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1638 | 0.040 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 166 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2009 | 4511 | 0.030 |
Why?
|
Ebola Vaccines | 1 | 2016 | 24 | 0.030 |
Why?
|
Fabaceae | 1 | 2017 | 103 | 0.030 |
Why?
|
Morbidity | 1 | 2022 | 1750 | 0.030 |
Why?
|
Lactic Acid | 1 | 2021 | 1139 | 0.030 |
Why?
|
Biological Clocks | 1 | 2018 | 318 | 0.030 |
Why?
|
Medical Audit | 1 | 2017 | 453 | 0.030 |
Why?
|
Clinical Coding | 1 | 2017 | 181 | 0.030 |
Why?
|
Mexican Americans | 1 | 2017 | 167 | 0.030 |
Why?
|
Economics, Hospital | 1 | 2018 | 210 | 0.030 |
Why?
|
Prognosis | 4 | 2021 | 29625 | 0.030 |
Why?
|
Puerto Rico | 1 | 2017 | 376 | 0.030 |
Why?
|
Microvessels | 1 | 2020 | 577 | 0.030 |
Why?
|
Hypoventilation | 1 | 2015 | 44 | 0.030 |
Why?
|
Genetic Variation | 1 | 2011 | 6567 | 0.030 |
Why?
|
United Nations | 1 | 2016 | 150 | 0.030 |
Why?
|
Catheterization, Central Venous | 1 | 2020 | 527 | 0.030 |
Why?
|
Diet, Sodium-Restricted | 1 | 2017 | 292 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 413 | 0.030 |
Why?
|
Nuts | 1 | 2017 | 264 | 0.030 |
Why?
|
Waist Circumference | 1 | 2018 | 935 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1682 | 0.030 |
Why?
|
Sex Factors | 2 | 2018 | 10552 | 0.030 |
Why?
|
Mexico | 1 | 2017 | 764 | 0.030 |
Why?
|
Pregnancy | 2 | 2013 | 29874 | 0.030 |
Why?
|
Body Mass Index | 3 | 2018 | 12953 | 0.030 |
Why?
|
Genes, env | 1 | 2013 | 95 | 0.030 |
Why?
|
Neck | 1 | 2018 | 734 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1349 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2020 | 846 | 0.030 |
Why?
|
Age Distribution | 1 | 2019 | 2880 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2020 | 1017 | 0.030 |
Why?
|
Tidal Volume | 1 | 2015 | 488 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3579 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39106 | 0.030 |
Why?
|
Recurrence | 2 | 2021 | 8465 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2011 | 21012 | 0.030 |
Why?
|
Psychometrics | 1 | 2023 | 3065 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1505 | 0.030 |
Why?
|
Colon | 1 | 2021 | 1792 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9280 | 0.030 |
Why?
|
Safety | 1 | 2017 | 1150 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2017 | 1444 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1814 | 0.020 |
Why?
|
Molecular Epidemiology | 1 | 2014 | 469 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2017 | 740 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18395 | 0.020 |
Why?
|
Fruit | 1 | 2017 | 1160 | 0.020 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2016 | 420 | 0.020 |
Why?
|
Drug Therapy, Combination | 3 | 2006 | 6310 | 0.020 |
Why?
|
Geography | 1 | 2013 | 656 | 0.020 |
Why?
|
Codon | 1 | 2013 | 601 | 0.020 |
Why?
|
Family Characteristics | 1 | 2016 | 1004 | 0.020 |
Why?
|
Temperature | 1 | 2017 | 2226 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6814 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2787 | 0.020 |
Why?
|
Health Resources | 1 | 2017 | 935 | 0.020 |
Why?
|
Goals | 1 | 2016 | 711 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1813 | 0.020 |
Why?
|
Triglycerides | 1 | 2018 | 2461 | 0.020 |
Why?
|
Violence | 1 | 2017 | 936 | 0.020 |
Why?
|
Base Sequence | 2 | 2011 | 12441 | 0.020 |
Why?
|
Suppression, Genetic | 1 | 2010 | 190 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2023 | 7045 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 23995 | 0.020 |
Why?
|
Energy Intake | 1 | 2017 | 2134 | 0.020 |
Why?
|
Arousal | 1 | 2015 | 1166 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 12990 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 1432 | 0.020 |
Why?
|
Monocytes | 1 | 2018 | 2570 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 1668 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2188 | 0.020 |
Why?
|
HLA-B Antigens | 1 | 2010 | 317 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2330 | 0.020 |
Why?
|
Observation | 1 | 2010 | 310 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3335 | 0.020 |
Why?
|
Respiration | 1 | 2015 | 1657 | 0.020 |
Why?
|
Research | 1 | 2017 | 1982 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2598 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2014 | 2341 | 0.020 |
Why?
|
Axilla | 1 | 2011 | 624 | 0.020 |
Why?
|
Movement | 1 | 2015 | 1478 | 0.020 |
Why?
|
Infant | 1 | 2010 | 36192 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9326 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2508 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2011 | 828 | 0.020 |
Why?
|
Tight Junctions | 1 | 2010 | 324 | 0.020 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2018 | 1393 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2011 | 732 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2850 | 0.020 |
Why?
|
Communicable Disease Control | 1 | 2014 | 846 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1902 | 0.020 |
Why?
|
Heart | 1 | 2020 | 4404 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2004 | 10194 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2011 | 1336 | 0.020 |
Why?
|
Mortality | 1 | 2017 | 2901 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15266 | 0.020 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1727 | 0.020 |
Why?
|
South Africa | 1 | 2011 | 1842 | 0.020 |
Why?
|
Genome, Viral | 1 | 2009 | 667 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6425 | 0.020 |
Why?
|
Health Policy | 1 | 2018 | 2684 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2010 | 868 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12059 | 0.020 |
Why?
|
Education, Medical | 1 | 2017 | 1725 | 0.020 |
Why?
|
Tumor Burden | 1 | 2011 | 1893 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2009 | 899 | 0.020 |
Why?
|
Point Mutation | 1 | 2010 | 1595 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2011 | 1271 | 0.010 |
Why?
|
Medicaid | 1 | 2018 | 2818 | 0.010 |
Why?
|
Animals | 4 | 2022 | 168459 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2011 | 1784 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1459 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3810 | 0.010 |
Why?
|
DNA, Viral | 1 | 2011 | 2202 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2510 | 0.010 |
Why?
|
Gene Frequency | 1 | 2011 | 3606 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3826 | 0.010 |
Why?
|
Sequence Analysis, RNA | 1 | 2011 | 2020 | 0.010 |
Why?
|
Glucose | 1 | 2015 | 4346 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2915 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22176 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9646 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4575 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2009 | 1264 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2003 | 681 | 0.010 |
Why?
|
Pain | 1 | 2017 | 5073 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2004 | 778 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22169 | 0.010 |
Why?
|
HIV Protease Inhibitors | 1 | 2004 | 432 | 0.010 |
Why?
|
Biomedical Research | 1 | 2017 | 3429 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1745 | 0.010 |
Why?
|
Neoplasms | 1 | 2010 | 22170 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26198 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13446 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2898 | 0.010 |
Why?
|
Acute Disease | 1 | 2009 | 7237 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7879 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 4915 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2009 | 4740 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3448 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17635 | 0.010 |
Why?
|
Genome, Human | 1 | 2010 | 4425 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11121 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2017 | 8599 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17904 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2010 | 2895 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 12795 | 0.010 |
Why?
|
Glioblastoma | 1 | 2010 | 3482 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2010 | 4026 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 16981 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2010 | 7856 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81525 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9177 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15936 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5840 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9318 | 0.000 |
Why?
|
Phenotype | 1 | 2004 | 16591 | 0.000 |
Why?
|